Outline

JEIM

Artificial Intelligence-Based Extraction of Inflammatory Bowel Disease Activity Indicators from Electronic Health Records for Real-World Treatment Effectiveness Evaluation

Author(s): Atul Janardhan Butte1,2, V A Rudrapatna1, B Scott1
1Bakar Computational Health Sciences Institute, University of California, San Francisco, USA.
2Center for Data-Driven Insights and Innovation, University of California Health System, Oakland, USA.
[mla_citation]

Abstract

Real-world evidence derived from electronic health records (EHRs) is increasingly recognized as a valuable resource for evaluating treatment effectiveness outside randomized clinical trials. However, diseases characterized by complex activity measures, such as inflammatory bowel disease (IBD), present significant challenges because relevant clinical variables are frequently documented in narrative clinical notes rather than structured fields. In this study, we develop an artificial intelligence-based natural language processing (NLP) framework designed to extract disease activity indicators from EHR narratives in patients treated with tofacitinib. The system identifies clinical symptoms, laboratory findings, and physician assessments necessary for calculating standardized disease activity scores such as the Mayo score and Crohn’s Disease Activity Index (CDAI). Using annotated clinical data, we trained transformer-based models to extract disease indicators with high precision and recall. The extracted data were used to reconstruct disease activity scores and evaluate treatment outcomes in real-world clinical settings. Our findings demonstrate that automated information extraction can significantly enhance the utility of EHR data for observational research and real-world evidence generation in complex chronic diseases.

Keywords
Inflammatory bowel disease, electronic health records, real-world evidence, artificial intelligence, natural language processing.

Related Articles

Azra Nishat1, Shazadi Sultana2, Arshiya Sultana2
1Department of Obstetrics and Gynecology, Government Nizamia Tibbi College Charminar, Hyderabad, India
2Department of Obstetrics and Gynecology, National Institute of Unani Medicine, PG Institute of Research, Bengaluru, Karnataka, India.
Rinaldo Bellomo1,2, John A. Kellum3, Claudio Ronco4
1Department of Intensive Care, Austin Hospital, Melbourne, Australia
2School of Medicine, The University of Melbourne, Australia
3Center for Critical Care Nephrology, University of Pittsburgh, USA.
4International Renal Research Institute, Vicenza, Italy.
Ivica Letunic1, Lars Nielsen1, Peer Bork2,3
1Biobyte solutions GmbH, Bothestr 142, 69126 Heidelberg, German
2EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
3Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany.
Michael Henderson1, Carol Inatsuka2, Amanda J. Sheets1, Corinne L. Williams3, David J. Benaron2, Gina M. Donato4, Mary C. Gray4, Erik L. Hewlett4, Peggy A. Cotter1,3
1Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, USA.
2Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA.
3Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA
4Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, USA
Eisha Nisar1, Rong Chen2, Atul Janardhan Butte2
1Faisalabad Medical University, faisalabad, Pakistan.
2Lucile Packard Children’s Hospital, Palo Alto, California, USA.
Olusola Ayanniyi1, Olusoji G. Ige2
1Department of Physiotherapy, College of Medicine, University of Ibadan, Ibadan, Nigeria.
2Physiotherapy Department, College of Medicine, University of Ibadan/UCH, Ibadan, Nigeria.